In breast and lung cancers, CCBE1 has been shown to be a potential tumor suppressor [14, 15], while in gastrointestinal stromal tumors (GISTs), CCBE1 enhances tumor angiogenesis [16]. This evidence concerns the gene CCBE1 and lung carcinoma.